Canada - TSX:DN - CA2477541049 - Common Stock
The current stock price of DN.CA is 0.01 CAD. In the past month the price decreased by -33.33%. In the past year, price decreased by -84.62%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| BHC.CA | BAUSCH HEALTH COS INC | 1.76 | 3.49B | ||
| TLRY.CA | TILRAY BRANDS INC | N/A | 1.90B | ||
| CRON.CA | CRONOS GROUP INC | 24.79 | 1.33B | ||
| DHT-UN.CA | DRI HEALTHCARE TRUST | 7.09 | 841.65M | ||
| GUD.CA | KNIGHT THERAPEUTICS INC | N/A | 605.06M | ||
| WEED.CA | CANOPY GROWTH CORP | N/A | 524.29M | ||
| CPH.CA | CIPHER PHARMACEUTICALS INC | 22.79 | 375.12M | ||
| HITI.CA | HIGH TIDE INC | N/A | 357.64M | ||
| ACB.CA | AURORA CANNABIS INC | N/A | 347.63M | ||
| TSND.CA | TERRASCEND CORP | N/A | 306.88M | ||
| OGI.CA | ORGANIGRAM GLOBAL INC | N/A | 282.09M | ||
| NGEN.CA | NERVGEN PHARMA CORP | N/A | 238.58M |
Delta 9 Cannabis, Inc. is a vertically integrated cannabis company, which engages in the production of medical and recreational cannabis products. The company is headquartered in Winnipeg, Manitoba and currently employs 200 full-time employees. The company went IPO on 2004-03-31. The firm operates through three segments: Wholesale Cannabis, Retail Cannabis and Merchandise and Devices, and Business to Business. The firm sells cannabis products through its wholesale and retail sales channels and sells its cannabis growing pods to other businesses. Its cannabis products include dried cannabis and pre-rolled joints. Its edibles and vapes include vape pens and concentrates, edibles, and drinkables. The Company, through its wholly owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical and recreational cannabis products and operates a 95,000-square-foot Health Canada licensed production facility in Winnipeg, Manitoba, Canada. The company also owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand. The company is focused on producing and selling cannabis oils, extracts, and derivative products.
DELTA 9 CANNABIS INC
PO Box 68096 Osborne Village
Winnipeg MANITOBA R3L 2V9 CA
CEO: John William Arbuthnot
Employees: 200
Phone: 12049975328
Delta 9 Cannabis, Inc. is a vertically integrated cannabis company, which engages in the production of medical and recreational cannabis products. The company is headquartered in Winnipeg, Manitoba and currently employs 200 full-time employees. The company went IPO on 2004-03-31. The firm operates through three segments: Wholesale Cannabis, Retail Cannabis and Merchandise and Devices, and Business to Business. The firm sells cannabis products through its wholesale and retail sales channels and sells its cannabis growing pods to other businesses. Its cannabis products include dried cannabis and pre-rolled joints. Its edibles and vapes include vape pens and concentrates, edibles, and drinkables. The Company, through its wholly owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical and recreational cannabis products and operates a 95,000-square-foot Health Canada licensed production facility in Winnipeg, Manitoba, Canada. The company also owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand. The company is focused on producing and selling cannabis oils, extracts, and derivative products.
The current stock price of DN.CA is 0.01 CAD.
DN.CA does not pay a dividend.
DN.CA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
DELTA 9 CANNABIS INC (DN.CA) currently has 200 employees.
DELTA 9 CANNABIS INC (DN.CA) has a market capitalization of 1.87M CAD. This makes DN.CA a Nano Cap stock.
DELTA 9 CANNABIS INC (DN.CA) will report earnings on 2024-08-12.
ChartMill assigns a fundamental rating of 2 / 10 to DN.CA. Both the profitability and financial health of DN.CA have multiple concerns.
Over the last trailing twelve months DN.CA reported a non-GAAP Earnings per Share(EPS) of -0.1. The EPS increased by 46.33% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -27.91% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
8 analysts have analysed DN.CA and the average price target is 0.06 CAD. This implies a price increase of 512% is expected in the next year compared to the current price of 0.01.